TIM
INFI

Tortoise Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Tortoise Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed – – 575
2018
Q2 		$0 Hold
100
– – ﹤0.01% 580
2018
Q1 		$0 Hold
100
– – ﹤0.01% 576
2017
Q4 		$0 Hold
100
– – ﹤0.01% 574
2017
Q3 		$0 Hold
100
– – ﹤0.01% 506
2017
Q2 		$0 Buy
+100
New +$193 ﹤0.01% 526

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Tortoise Investment Management's INFI Position: Q3 2018 in Review

Tortoise Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2018, closing a stake of 100 shares.

Tortoise Investment Management first reported a position in INFI in Q2 2017 and held it in 5 quarters. The position peaked at $0 in Q2 2018. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2018.

  • Tortoise Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Tortoise Investment Management sold 100 Infinity Pharmaceuticals, Inc. shares in Q3 2018.
  • Tortoise Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
  • Tortoise Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $0 in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2018.

Based on Tortoise Investment Management's 13F filing for Q3 2018, filed 20 Nov 2018.